Piramal Critical Care acquired brands and all related Intellectual Property, including know-how to make both API and finished dosage forms, of a line of Janssen injectable anaesthesia/pain management products, like Rapifen® (Alfentanil Hydrochloride) and Sublimaze® (Fentanyl Citrate).
